Argatroban 13C6
| Chemical Name | Argatroban 13C6 |
|---|---|
| Alternate Names | Argatroban Stable Isotopes, Stable Isotopes of Argatroban |
| CAT No. | CS-EK-01686 |
| CAS Registry# | 74863-84-6 unlabeled |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Argatroban |
| Canonical Smiles | CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C |
| InchIKey | KXNPVXPOPUZYGB-IOVMHBDKSA-N |
| Inchl | InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1 |
| IUPAC | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
[13C6]-Argatroban is a stable isotope-labeled form of Argatroban, a synthetic direct thrombin inhibitor that is used to prevent blood clotting in patients with heparin-induced thrombocytopenia. This form of Argatroban contains six carbon-13 isotopes, which can be used in research studies to track the metabolic fate of the drug in the body.
The chemical formula for [13C6]-Argatroban is C23H36N6O5S, and it has a molecular weight of 520.64 g/mol. It is a white to off-white powder that is soluble in water and ethanol. The drug is administered intravenously, and the dose is adjusted based on the patient's body weight, renal function, and coagulation parameters.
The pharmacological activity of [13C6]-Argatroban is similar to that of the non-labeled Argatroban. It binds reversibly to the active site of thrombin, inhibiting its ability to convert fibrinogen to fibrin and preventing the formation of blood clots. The drug has a short half-life of about 50 minutes, and it is primarily metabolized by the liver and excreted in the urine.
In research studies, [13C6]-Argatroban can be used to investigate the pharmacokinetics and pharmacodynamics of the drug in healthy volunteers or patients with heparin-induced thrombocytopenia. By measuring the levels of labeled drug in blood, urine, or other tissues, researchers can gain insights into the mechanisms of drug action, drug interactions, and drug metabolism.
Get an Instant Quote
Related Compounds
Argatroban D3 |